Cancer diagnosis relies fairly on clinical symptoms, imaging, detection of endogenous biomarkers in blood circulation, and invasive biopsies. (1) However, cancer progresses in silence featuring confusing symptoms, lesions below the level of imaging detection, low concentration levels of clinically relevant biomarkers in biofluids, and often limited tissue for sampling, curtailing the benefits...